Public Release: 21-Apr-2015 Trial shows benefit of 'BRCA-targeting' drug in ...
EurekAlert (press release)
Men with prostate cancer benefit from treatment with the pioneering drug olaparib - the first cancer drug to target inherited mutations - according to the results of a major trial presented today (Tuesday). Olaparib was licensed in December for women with ...
Posted by Shoaib-ur-Rehman Siddiqui
by via Health - Google News